Definium Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Definium Therapeutics, Inc. (DFTX) had Deferred Tax Assets, Operating Loss Carryforwards of $78.39 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $78.39M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $42.47M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $31.56M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $25.31M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $78.39M 10-K · filed 2026-02-26 |
| 2024-12-31 | $42.47M 10-K · filed 2026-02-26 |
| 2023-12-31 | $31.56M 10-K · filed 2025-03-06 |
| 2022-12-31 | $25.31M 10-K · filed 2024-02-28 |
| 2021-12-31 | $31.93M 10-K · filed 2023-03-09 |
| 2020-12-31 | $7.11M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |